Eurozone Private Sector Shrinks In November Amid Covid-19 Lockdowns

News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. (RTTNews) - The euro area private sector contracted sharply in November as member countries reintroduced more restrictions to counter the spread of Covid-19 infection, flash survey data from IHS Markit showed Monday. The composite output index plunged to a six-month low of 45.1 from the neutral 50.0 in October. The score was forecast to fall to 45.8. The further downturn of the economy signaled for the fourth quarter represents a major set-back to the region's health and extends the recovery period, Chris Williamson, chief business economist at IHS Markit said. After a 7.4 percent contraction of GDP in 2020, IHS Markit expects only a 3.7 percent expansion in 2021. The drop in the composite index to well below 50 adds to the evidence that the euro-zone economy will post another sizeable contraction in the fourth quarter, Jack Allen-Reynolds, an economist at Capital Economics, said. But with vaccines looking increasingly likely to be rolled out in the first half of next year, the surveys show greater optimism about 2021. The deteriorating performance was broad-based, albeit with the service sector hardest hit from virus containment measures. The services Purchasing Managers' Index slid to 41.3 from 46.9 in the previous month. The reading To keep reading about Eurozone Private Sector Shrinks In November Amid Covid-19 Lockdowns, Click on the link. Seoul, Korea
http://dlvr.it/RmFJfw

Comments

Post a Comment

Popular posts from this blog

AstraZeneca Begins Phase I Trial Of AZD7442 Against COVID-19 – Quick Facts

Image
(RTTNews) - AstraZeneca Plc (AZN.L, AZN) said first participants have been dosed in a Phase I trial of AZD7442 for the prevention and treatment of COVID-19. The trial will evaluate the safety, tolerability and pharmacokinetics of AZD7442. It will include up to 48 healthy participants in the UK aged 18 to 55 years. AZD7442 is a combination of two monoclonal antibodies derived from convalescent patients with SARS-CoV-2 infection. Discovered by Vanderbilt University Medical Center and licensed to AstraZeneca in June 2020, the mAbs were optimised by AstraZeneca. Data readout from the trial is anticipated in the second half of 2020. To keep reading about AstraZeneca Begins Phase I Trial Of AZD7442 Against COVID-19 – Quick Facts, Click on the link. Seoul, Korea http://dlvr.it/RfHgSK
Read more

7 lies to stop telling yourself if you want to become mentally stronger

Image
Crystal Cox/Business Insider Amy Morin is a psychotherapist, licensed clinical social worker, mental strength coach, and international bestselling author. She explains that sometimes our own thoughts can hold us back, especially if we tend to dwell on negative events, insecurities, and self-doubt. Morin says it's important to confront thoughts like "I'm not good enough" or "I'm too damaged," and replace them with self-empathy by instead saying "I am worth it" or "I'm a survivor." Visit Business Insider's homepage for more stories. Many of the things you tell yourself aren't true. And there's a good chance you've bought into some unhealthy beliefs over the years. Courtesy of Amy Morin In the therapy world, we call these "cognitive distortions." We all have them. Learning to recognize these lies we tell ourselves and replace them with healthier, more realistic statements is key to building mental str...
Read more